Follow the Nuo Therapeutics, Inc. share price and the full management transaction log of the company, a listed equity based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Operating in the Health Care sector, Nuo Therapeutics, Inc. has logged 32 public disclosures. Market capitalisation: €53.3m. The latest transaction was disclosed on 31 August 2026 (Acquisition). Among the most active insiders: JORDEN DAVID EMERSON. Every trade is accessible without an account.
32
Insider Decl.
n/a
Thresholds
€1m
8 ops.
Buy Volume
€303,263
2 ops.
Sell Volume
29Σ signal
Buys €1m€303,263 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,909 of 29,063 companies
34.2
score / 100
Value
26
Quality
42
FCF yld-2.1%
Earn yld-4.7%
EV/EBITDA·
ROE·
Gross mgn67%
Net mgn-76%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.